Evidence map›Paper›PMID 22615412›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Notch controls the magnitude of T helper cell responses by promoting cellular longevity.

Christina Helbig, Rebecca Gentek, Ronald A Backer, Yevan de Souza, Ingrid A M Derks, Eric Eldering, Koen Wagner, Dragana Jankovic, Thomas Gridley, Perry D Moerland and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Notch2-expressing CD4Cellular & molecular immunology · 2025
    Article
  2. Article
  3. Review
  4. Inflammation durably imprints memory CD4+ T cells.bioRxiv : the preprint server for biology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Targeting the Notch Pathway to Prevent Rejection.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christina HelbigDepartment of Cell Biology and Histology, Academic Medical Center, 1105AZ Amsterdam, The Netherlands.
Rebecca Gentek
Ronald A Backer
Yevan de Souza
Ingrid A M Derks
Eric Eldering
Koen Wagner
Dragana Jankovic
Thomas Gridley
Perry D Moerland
Richard A Flavell
Derk Amsen

Funding

Immune Regulation In Toxoplasmosis And Other Opportunistic InfectionsZIAAI000579 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$7.8M
GENETIC CONTROL OF MESODERM AND NEURAL CREST FORMATIONR01HD034883 · NICHD · MAINEHEALTH · PI GRIDLEY, THOMAS HOOKER · 1998 to 2012
$4.4M
Howard Hughes Medical InstituteNICHD NIH HHS HD034883NICHD NIH HHS R01 HD034883
6 · The paper itself

Abstract

Generation of effective immune responses requires expansion of rare antigen-specific CD4(+) T cells. The magnitude of the responding population is ultimately determined by proliferation and survival. Both processes are tightly controlled to limit responses to innocuous antigens. Sustained expansion occurs only when innate immune sensors are activated by microbial stimuli or by adjuvants, which has important implications for vaccination. The molecular identity of the signals controlling sustained T-cell responses is not fully clear. Here, we describe a prominent role for the Notch pathway in this process. Coactivation of Notch allows accumulation of far greater numbers of activated CD4(+) T cells than stimulation via T-cell receptor and classic costimulation alone. Notch does not overtly affect cell cycle entry or progression of CD4(+) T cells. Instead, Notch protects activated CD4(+) T cells against apoptosis after an initial phase of clonal expansion. Notch induces a broad antiapoptotic gene expression program that protects against intrinsic, as well as extrinsic, apoptosis pathways. Both Notch1 and Notch2 receptors and the canonical effector RBPJ (recombination signal binding protein for immunoglobulin kappa J region) are involved in this process. Correspondingly, CD4(+) T-cell responses to immunization with protein antigen are strongly reduced in mice lacking these components of the Notch pathway. Our findings, therefore, show that Notch controls the magnitude of CD4(+) T-cell responses by promoting cellular longevity.

Indexed as

AnimalsApoptosisCell SurvivalFlow CytometryHemocyaninsImmunizationMiceMice, Inbred C57BLMicroarray AnalysisReal-Time Polymerase Chain ReactionReceptors, NotchSignal TransductionT-Lymphocytes, Helper-InducerHemocyaninskeyhole-limpet hemocyaninReceptors, Notch

Identifiers

PMID22615412
PMCPMC3384214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.